Insights
- Latest
- Trending
- Bonds
- ETFs
- Mutual Funds
- Private Wealth
- REITs
- Retirement
- Savings
- Singapore Depository Receipts
- Stocks
- Trading
- Commodities
Research
Reviews
Screeners
- Best Singapore REITs
  
  Find the best Singapore REITs for your portfolio
- Best Singapore Dividend Stocks
  
  Top Singapore dividend-paying stocks with an upside to consensus target price and a dividend yield of above 3%
- Best Singapore High Dividend Stocks
  
  Top Singapore dividend-paying stocks with a dividend yield of above 4%
- Upcoming Dividends
  
  Singapore stocks, REITs and ETFs with upcoming dividend payments
- View All Securities
Tools
- US Fed Funds Interest Rate Tracker
  
  Stay informed on the United States Fed Funds Interest Rate with real-time updates, historical trends, and key insights
- SSB Interest Rate Projection
  
  Discover the projected interest rate for the next Singapore Savings Bond (SSB) issuance
- Passive Income Calculator
  
  Find out how much income you can potentially earn on your fixed deposits, bonds and stock holdings.
- View All Tools
Investing 101
- Beginner’s Guide to Start Investing in Singapore
  
  Learn how to start investing in Singapore to grow your money
- Singapore REITs
  
  All-in-one place to learn about the fundamental, sector breakdown and the latest insights and performance of REITs
- Singapore Mutual Funds
  
  All-in-one place to learn the benefits, types and insights of mutual funds in Singapore
- Singapore ETFs
  
  Learn the basics of ETFs, see the latest ETF highlight and access the top resources by SGX
- Singapore DLCs
  
  Learn the basics of DLCss, see the latest DLCs highlight and access the top resources by SGX
Podcasts
About
- Company
- Events
- Partners
Promo

CHINA SUNSINE CHEM HLDGS LTD

SGX: QES

0.735

-0.68%

Share Price in SGD. As of 10 Feb 17:12:53 SGT

All

Chart

Beansprout Analysis

Market Analysis

Analyst Ratings

There is no analyst rating data currently available for CHINA SUNSINE CHEM HLDGS LTD.

Valuation

Earnings

Financials

News

Profile

Discussion

0 comments